BACKGROUND: The pathogenesis of cognitive deficits in multiple sclerosis (MS) patients is the subject of debate. A causative role of grey matter impairment has been suggested. Acetylcholinesterase inhibitors have been proposed in the treatment of cognitive impairment in MS. Short-latency afferent inhibition (SAI) is a cortical phenomenon assessed by a transcranial magnetic stimulation protocol that provides an in vivo index of central cholinergic function. METHODS: We recruited 20 consecutive relapsing-remitting or secondary progressive MS patients showing normal upper limb somatosensory and motor evoked potentials. SAI of the left-hand motor cortex from median nerve stimuli was tested. A matched group of 20 healthy subjects was also assessed. All patients underwent neuropsychological assessment with Rao's Brief Repeatable Battery (BRB). Multiple regression was performed on the number of failed tests and on scores of single BRB tests as dependent variables with Extended Disability Status Scale (EDSS) score, SAI, age, gender and disease duration as regressors. Patients with impaired SAI, were reassessed after a single oral dose of rivastigmine. RESULTS: SAI was a significant predictor of the score in tests that assess verbal memory. EDSS score and age were found as predictors of the other BRB tests. SAI was significantly improved by oral rivastigmine. CONCLUSIONS: Our data confirm that cognitive impairment in MS is multifactorial. The performances in the subdomain of verbal memory are predicted by SAI. These results favour the hypothesis of grey matter involvement and suggest a role of acetylcholine dysfunction in the pathogenesis of some aspects of cognitive deficits in MS.
BACKGROUND: The pathogenesis of cognitive deficits in multiple sclerosis (MS) patients is the subject of debate. A causative role of grey matter impairment has been suggested. Acetylcholinesterase inhibitors have been proposed in the treatment of cognitive impairment in MS. Short-latency afferent inhibition (SAI) is a cortical phenomenon assessed by a transcranial magnetic stimulation protocol that provides an in vivo index of central cholinergic function. METHODS: We recruited 20 consecutive relapsing-remitting or secondary progressive MSpatients showing normal upper limb somatosensory and motor evoked potentials. SAI of the left-hand motor cortex from median nerve stimuli was tested. A matched group of 20 healthy subjects was also assessed. All patients underwent neuropsychological assessment with Rao's Brief Repeatable Battery (BRB). Multiple regression was performed on the number of failed tests and on scores of single BRB tests as dependent variables with Extended Disability Status Scale (EDSS) score, SAI, age, gender and disease duration as regressors. Patients with impaired SAI, were reassessed after a single oral dose of rivastigmine. RESULTS: SAI was a significant predictor of the score in tests that assess verbal memory. EDSS score and age were found as predictors of the other BRB tests. SAI was significantly improved by oral rivastigmine. CONCLUSIONS: Our data confirm that cognitive impairment in MS is multifactorial. The performances in the subdomain of verbal memory are predicted by SAI. These results favour the hypothesis of grey matter involvement and suggest a role of acetylcholine dysfunction in the pathogenesis of some aspects of cognitive deficits in MS.
Authors: Alan H Lockwood; Richard T Linn; Herman Szymanski; Mary Lou Coad; David S Wack Journal: J Int Neuropsychol Soc Date: 2004-01 Impact factor: 2.892
Authors: M Filippi; C Tortorella; M Rovaris; M Bozzali; F Possa; M P Sormani; G Iannucci; G Comi Journal: J Neurol Neurosurg Psychiatry Date: 2000-02 Impact factor: 10.154
Authors: M P Amato; E Portaccio; B Goretti; V Zipoli; L Ricchiuti; M F De Caro; F Patti; R Vecchio; S Sorbi; M Trojano Journal: Mult Scler Date: 2006-12 Impact factor: 6.312
Authors: Maria Pia Amato; Emilio Portaccio; Benedetta Goretti; Valentina Zipoli; Marco Battaglini; Maria Letizia Bartolozzi; Maria Laura Stromillo; Leonello Guidi; Gianfranco Siracusa; Sandro Sorbi; Antonio Federico; Nicola De Stefano Journal: Arch Neurol Date: 2007-08
Authors: Ayda Tekok-Kilic; Ralph H B Benedict; Bianca Weinstock-Guttman; Michael G Dwyer; Dominic Carone; Bhooma Srinivasaraghavan; Viritha Yella; Nadir Abdelrahman; Frederick Munschauer; Rohit Bakshi; Robert Zivadinov Journal: Neuroimage Date: 2007-04-18 Impact factor: 6.556
Authors: Yoshihiro Noda; Mera S Barr; Reza Zomorrodi; Robin F H Cash; Tarek K Rajji; Faranak Farzan; Robert Chen; Tony P George; Zafiris J Daskalakis; Daniel M Blumberger Journal: Schizophr Bull Date: 2018-01-13 Impact factor: 9.306
Authors: Giuseppe Lanza; Francesco Fisicaro; Raffaele Dubbioso; Federico Ranieri; Andrei V Chistyakov; Mariagiovanna Cantone; Manuela Pennisi; Alfio Antonio Grasso; Rita Bella; Vincenzo Di Lazzaro Journal: Front Aging Neurosci Date: 2022-09-26 Impact factor: 5.702
Authors: Mario Stampanoni Bassi; Fabio Buttari; Luana Gilio; Nicla De Paolis; Diego Fresegna; Diego Centonze; Ennio Iezzi Journal: Front Neurol Date: 2020-07-07 Impact factor: 4.003